Monitor for additional Form 4 filings in the next 30 days, if selling accelerates above 0.1% of market cap or includes the CEO/CFO, the signal strengthens. For now, the small dollar amount relative to XERS's $1.5B market cap makes this a neutral data point; the stock's recent strength and strong analyst coverage suggest no bearish read-through.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 2 $8.58entry
- T+1 · 3mo ago +0.12%α −0.93% · $8.59
- T+5 · 2mo ago −10.61%α −9.65% · $7.67
- T+20 · 7w ago +11.42%α +11.51% · $9.56
- T+52 · todayOpen
- T+60 · in 10d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Xeris Biopharma insiders (McCulloch, Hecht, Pieper) sold a combined $311K in open-market shares on September 1, 2026 at ~$8.49-$8.50 per share. While a cluster of C-suite selling is notable, the total value represents ~0.02% of the $1.5B market cap, well below the 0.1% materiality threshold, and the sales coincide with the stock near multi-year highs, suggesting routine portfolio diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- Three executives, McCulloch, Hecht, Pieper, sold a total of $311,242 in open-market sales on September 1, 2026
- Sales executed at $8.49-$8.50 per share, near XERS's recent highs
- Total sales equal ~0.02% of the $1.5B market cap, well below the 0.1% materiality threshold
- All three sellers have 'See Remarks' titles, likely C-suite or senior operational roles
Financial Impact
Open-market sales of $311K represent ~0.02% of market cap
Risk Factors
- Sales could accelerate if insiders diversify further ahead of potential Q3 2026 earnings
- Stock at multi-year highs may invite profit-taking by other holders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-XERS-1788301306922 |
Track record
25 reports on XERS
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +45.52% at T+60 after the Aug 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $15.86 Now $16.70 +5.30% settles Dec 8
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $15.20 Now $16.70 +9.87% settles Dec 7
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago 3 Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $10.35 Now $16.70 +61.35% settles Dec 2
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $10.17 Now $16.70 +64.21% settles Dec 1
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $10.71 Now $16.70 +55.93% settles Nov 30
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $9.77 to $16.52 Now $16.70 +70.93% ▲ +69.09% +70.36% vs SPY
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $10.13 to $10.71 Now $16.70 +64.86% ▲ +5.73% +8.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers